Skip to main content

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?

Johnson, Miriam; Johnson, M.; Maraveyas, A.

Authors

A. Maraveyas A.Maraveyas@hull.ac.uk



Abstract

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is still limited. Limitations can be related to the thromboembolism itself, the underlying cancer, or to the management process. There is significant literature that deals with the first two, but very little regarding the systems we use, or how the inadequacies in documentation, identification and classification of VTE affect the cancer patients themselves. This review aims to raise awareness of this neglected area and stimulate research that may lead to improvements in patient care

Journal Article Type Article
Publication Date Jun 16, 2009
Journal Br.J.Cancer
Print ISSN 0007-0920
Electronic ISSN 1532-1827
Publisher Cancer Research UK
Peer Reviewed Peer Reviewed
Volume 100
Issue 12
Pages 1837-1841
APA6 Citation Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?. The British journal of cancer / Cancer Research Campaign, 100(12), 1837-1841. doi:10.1038/sj.bjc.6605091
DOI https://doi.org/10.1038/sj.bjc.6605091
Keywords classification; Disease; epidemiology; Morbidity; mortality; Research; Thromboembolism
;